Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 1/20 | 0.50 |
| ▸ | ADH1C | P00326 | 1/20 | 0.50 |
| ▸ | ADH1A | P07327 | 1/20 | 0.50 |
| ▸ | ADH4 | P08319 | 1/20 | 0.50 |
| ▸ | ADH7 | P40394 | 1/20 | 0.50 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | MTOR | P42345 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10711541 | 1.00 | ADH1B (0.50) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL27892830 | 1.00 | ADH1B (0.50) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL11801944 | 1.00 | ADH1B (0.50) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL11808505 | 1.00 | ADH1B (0.50) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL27511566 | 1.00 | ADH1B (0.50) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL11801408 | 1.00 | ADH1B (0.50) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL11802666 | 1.00 | ADH1B (0.50) | ADH1BADH1CADH1AADH4ADH7 | |
| Hydrochloric Acid SCHEMBL28447688 | 0.98 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| Hydrochloric Acid SCHEMBL28604108 | 0.98 | ADH1B (0.48) | ADH1BADH1CADH1AADH4ADH7 | |
| SCHEMBL7565736 | 0.98 | ADH1B (0.47) | ADH1BADH1CADH1AADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022228806-A1 | BIPHASIC COSMETIC COMPOSITION AND APPLICATION THEREOF | BASF SE (DE) | 2022-11-03 | — | — | WO | claimed |
| EP-3134184-B1 | COMPOSITIONS IN THE FORM OF DISSOLVABLE SOLID STRUCTURES | PROCTER & GAMBLE (US) | 2024-04-10 | — | — | EP | disclosed |
| EP-4172337-A1 | APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS | The Procter & Gamble Company (US) | 2023-05-03 | — | — | EP | disclosed |
| WO-2021262911-A1 | APTAMERS FOR PERSONAL HEALTH CARE APPLICATIONS | THE PROCTER & GAMBLE COMPANY (US) | 2021-12-30 | — | — | WO | disclosed |
| WO-2019109243-A1 | Cosmetic composition for permanently changing the shape of keratinous fibers | HENKEL AG & CO.KGAA (DE) | 2019-06-13 | — | — | WO | disclosed |
| WO-2018207078-A1 | STYRENE BUTADIENE LATEX BINDER FOR WATERPROOFING APPLICATIONS | BASF SE (DE) | 2018-11-15 | — | — | WO | disclosed |
| EP-2419077-B1 | PROCESS OF TREATING DAMAGED HAIR | RHODIA OPERATIONS (FR) | 2016-10-12 | — | — | EP | disclosed |
| EP-2393469-B1 | Process of treating hair | RHODIA OPERATIONS (FR) | 2016-10-12 | — | — | EP | disclosed |
| US-9187716-B2 | Structured surfactant system | RHODIA OPERATIONS (FR) | 2015-11-17 | — | — | US | disclosed |
| US-20140308227-A1 | PROCESS OF TREATING DAMAGED HAIR | RHODIA OPERATIONS (FR) | 2014-10-16 | — | — | US | disclosed |
| CN-1809593-B | Galactomannan hydrocolloids | LUBRIZOL ADVANCED MAT INC | 2010-11-24 | — | — | CN | disclosed |
| WO-2010118925-A2 | PROCESS OF TREATING DAMAGED HAIR | RHODIA OPERATIONS (FR) | 2010-10-21 | — | — | WO | disclosed |
| WO-2010089228-A1 | AQUEOUS COMPOSITION SUITABLE AS SHAMPOO | RHODIA OPERATIONS (FR) | 2010-08-12 | — | — | WO | disclosed |
| EP-2216010-A1 | Aqueous composition suitable as shampoo | Rhodia Opérations (FR) | 2010-08-11 | — | — | EP | disclosed |
| EP-2136768-A1 | STRUCTURED SURFACTANT COMPOSITIONS | Rhodia, Inc. (US) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008118381-A1 | STRUCTURED SURFACTANT COMPOSITIONS | RHODIA INC. (US) | 2008-10-02 | — | — | WO | disclosed |
| US-20080233061-A1 | Alkyl ether sulfate surfactant, alkyl sulfate surfactant, alkanolamide surfactant,amphoteric surfactant, and electrolyte; opacity, yield strength; sodium trideceth sulfate, sodium lauryl sulfate, ammonium lauryl sulfate, sodium lauroamphoacetate, coco monoethanolamide, ammonium chloride, citric acid | SPECIALTY OPERATIONS FRANCE (FR) | 2008-09-25 | — | — | US | disclosed |
| US-20080095733-A1 | Structured surfactant system | RHODIA OPERATIONS (FR) | 2008-04-24 | — | — | US | disclosed |
| CN-1886126-A | Methods and products which utilize N-acyl-L-aspartic acid | DMI BIOSCIENCES INC (US) | 2006-12-27 | — | — | CN | disclosed |
| CN-1809593-A | Galactomannan hydrocolloids | NOVEON IP HOLDINGS CORP (US) | 2006-07-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080233061-A1 | Alkyl ether sulfate surfactant, alkyl sulfate surfactant, alkanolamide surfactant,amphoteric surfactant, and electrolyte; opacity, yield strength; sodium trideceth sulfate, sodium lauryl sulfate, ammonium lauryl sulfate, sodium lauroamphoacetate, coco monoethanolamide, ammonium chloride, citric acid | SGMS2, SGMS1, ACMSD | ADH1B 3714/4885ADH1C 1649/4885ADH1A 1477/4885 |
| US-20080095733-A1 | Structured surfactant system | TTR, SPAST, SMURF1 | ADH1B 4402/4885ADH1C 3175/4885ADH1A 3741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.